期刊文献+

PCNA与bcl-2,P_(16),P_(53)基因在子宫内膜不典型增生及癌变组织中表达的相关性

The Association between PCNA and bcl-2,P_(16) ,P_(53) Gene Expression in Endometrial Atypical Hyperplasia and in Endometrial Carcinoma
下载PDF
导出
摘要 目的 探讨增殖细胞核抗原 (PCNA)及细胞凋亡相关基因bcl 2 ,P16,P53 在子宫内膜不典型增生(EAH)与内膜癌变 (EC)组织中表达的相关性。方法 应用免疫组织化学技术分别对 33例子宫内膜癌 ,35例子宫内膜不典型增生 ,30例单纯性子宫内膜增生 (ESH)组织进行PCNA和bcl 2 ,P16,P53 基因蛋白定位、表达程度、对比差异 ,分析它们之间的关系。结果 EC组和EAH组PCNA ,bcl 2均有阳性表达 ,两组间差异无显著性 ,其表达强度由中到强阳性 ,但这两种在EC和EAH组中表达与其在ESH组比较 ,差异有显著性 (P <0 .0 1)。P16基因随细胞分化程度下降 ,ESH组阳性率 93.33% ,EAH和EC组分别为 74 .2 8% ,6 3.6 4% ,ESH组明显高于EAH组 (P <0 .0 5 )与EC组 (P <0 .0 1) ,而后两者差异无显著性 ,其定位ESH组基因表达均在细胞浆 ,而EAH和EC组基因表达见于细胞核或核浆共同表达。P53 基因在ESH组无阳性表达 ,EAH组阳性率 2 2 .86 % ,EC组阳性率 5 4.5 5 % ,两组比较差异有显著性 (P <0 .0 1)。结论 PCNA ,bcl 2 ,P53 表达在子宫内膜增殖性病变、细胞恶性转化的进程中呈递增趋势 ,而P16趋于递减 ,提示细胞的过度增殖和增殖 凋亡相关基因的表达失衡在子宫内膜恶性转化过程中起重要作用 。 Objective To investigate the association between proliferation cell nucleus antigen (PCNA) and bcl 2,P 16 ,P 53 cell apoptosis gene expression in endometrial atypical hyperplasia (EAH) and endometrial carcinoma (EC).Methods The PCNA,bcl 2,P 16 and P 53 gene expression was examined ,analysedand compared in 33 cases with EC,35 cases with EAH and 30 cases with endometrial simple hyperplasia (ESH) by immunohistochemical method.Results There expression of PCNA and bcl 2 in EC and EAH showed positive,from moderate to strong,with no significant difference between the two groups but significantly higher than that in ESH(P<0.01).The P 16 gene expression decreased with the decrease of cell differentiation.The positive rate in ESH,EAH,EC was 93.33%,74.28%,63.64% respectively.The positive rate in ESH was significantly higher than that in EAH (P<0.05) and EC (P<0.01),but no significant difference between the latter two groups.The P 16 gene expression was detected in cellular plasm in ESH,but in cellular nucleus and/or cellular plasm in EAH and EC.The P 53 gene expression rate in ESH,EAH,EC was 0%,22.86%,54.55% respectively.There was a significant difference between the latter two groups (P<0.01).Conclusion The expression of PCNA,bcl 2,P 53 increases graduallyin endometrial hyperplasia disease and cell maligant transformation,but P 16 decreases.This indicates the out of balance between cell over proliferation and proliferation/apoptosis gene plays an important role in endometrial maligant transformation.The abnormal expression could help to diagnose the endometrial proliferation diseases and predict their biological behavior.
出处 《潍坊医学院学报》 2003年第1期21-24,共4页 Acta Academiae Medicinae Weifang
基金 潍坊市科技局资助课题 (课题编号 :2 0 0 1 0 35)
关键词 细胞增殖 基因 凋亡 内膜癌 不典型增生 单纯性增生 Cell proliferation Gene Apoptosis Endometrial carcinoma Atypical hyperplasia Simple hyperplasia
  • 相关文献

参考文献10

  • 1周春晓,孙建衡,陆士新,刘海玲,苏涛,金顺钱,盛修贵.子宫内膜癌中MTS1/p16基因缺失的研究[J].中华肿瘤杂志,1997,19(6):404-406. 被引量:26
  • 2生秀杰,宋和存,何秀琴.抗凋亡基因bcl-2在子宫内膜癌的表达及意义[J].中华肿瘤杂志,1998,20(5):365-366. 被引量:16
  • 3连利娟.子宫内膜不典型增生[A].见:连利娟.林巧稚妇科肿瘤学:第3版[C].北京:人民卫生出版社,2000.335~244.
  • 4荣风年,程红英,汤春生.对细胞凋亡的新认识[J].国外医学(妇产科学分册),2002,29(1):26-28. 被引量:5
  • 5Hall PA, Lerrison DA, Woods AL, et al. Proliferating cell nuclear antigen(PCNA) inmmnolocalization on in paraffin sections: an index of cell proliferation with evidence of desegulated expression in some neoplasms [ J ]. J Pathol, 1990,160:285.
  • 6Oyama T, Watanabe H, Iwafuchi M, et al. Diagistin value of proliferating cell nuclear antigen for myogerin tumors of the stomach [ J]. Gastrenterol Jpn, 1993,28:193.
  • 7Lane DP.A death in life of P53[J]. Nature, 1993,362:786 - 787.
  • 8Umekite Y, Kobayashi T. Nuclear accumulation of P53 protein correlates with mutations in the P53 gene on archival paraffin-embedded tissues of human breast cancer[J]. Jpn J Cnacer Res, 1994,85:825.
  • 9Shiozawa T,Nilaido T, Shimizu M, et al. Immunohistochemical analysis of the expression of cdR4 and P16 INK4 in human endometrioid -type endometrial carcinoma[J]. Cancer, 1997,80:2250 - 2256.
  • 10黄文斌,卢林明,齐琼.胃癌组织中CD44、PCNA的表达及其意义[J].实用癌症杂志,2000,15(4):356-358. 被引量:53

二级参考文献27

  • 1李锦清,张昌卿,张亚奇,冯凯涛,元云飞,陈敏山,郭荣平,林小军,李国辉.PCNA、p53蛋白在肝癌临床中的意义[J].癌症,1996,15(1):45-47. 被引量:22
  • 2傅松滨,国外医学.遗传学分册,1996年,19卷,6页
  • 3Xiao S,Cancer Res,1995年,55卷,2968页
  • 4Debatin K.Activation of apoptosis pathways by anticancer treatment.Toxicology Letters,2000,112-113:41-48
  • 5Kerr JFR,Wyllie AH,Currie AR.Apoptosis:A basic biological phenomenon with wild-ranging implications in tissue kinetics.Br J Cancer,1972,26:239-257
  • 6Brenner C,Marzo I,Kroemer G.A revolution in apoptosis:from a nucleocentric to a mitochondriocentric perspective.Exp Gerontol,1998,33 (6):543-553
  • 7Zhuang J,Dinsdale D,Cohen GM.Apoptosis,in human monocytic THP.1 cells,results in the release of cytochrome c from mitochondria prior to their ultrocondensation formation of outer membrane discontinuities and reduction in inner membrane potential.Cell Death Differ,1998,5(11):953-962
  • 8Kroemer G,Dallaporta B,Resche-Rigon M.The mitochondrial death/ life regulator in apoptosis and necrosis.Annu Rev Physiol,1998,60:619-642
  • 9Gross A,McDonnell JM,Korsmeyer SJ.BCL-2 family members and the mitochondria in apoptosis.Genes Dev,1999,13(15):1899-1911
  • 10Goping IS,Gross A,Lavoie JN,et al.Regulated targeting of Bax to mitochondrial.J Cell Biol,1998,143 (1):207-215

共引文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部